Jianji Pan

机构：Fujian Medical University, Shanghai Jiao Tong University, Renji Hospital, Zhangzhou Municipal Hospital of Fujian Province, Jinan Central Hospital, Fujian Provincial Cancer Hospital, Xiamen Chang Gung Hospital, Shandong First Medical University, Xiamen Maternal and Child Health Hospital · ORCID：0000-0002-3211-7874

发表论文 311 篇 · 总被引 7848 次 · h-index 48

代表论文

• Toripalimab Plus Chemotherapy for Recurrent or Metastatic Nasopharyngeal Carcinoma (2023 · JAMA · 被引 254)
• A Review of Planned, Ongoing Clinical Studies and Recent Development of BNCT in Mainland of China (2023 · Cancers · 被引 53)
• Methylglyoxal from gut microbes boosts radiosensitivity and radioimmunotherapy in rectal cancer by triggering endoplasmic reticulum stress and cGAS-STING activation (2023 · Journal for ImmunoTherapy of Cancer · 被引 48)
• Long-term trends in the burden of nasopharyngeal carcinoma in China: A comprehensive analysis from 1990 to 2021 and projections to 2030 based on the global burden of disease study 2021 (2024 · Radiotherapy and Oncology · 被引 36)
• Long-term trends and future projections of larynx cancer burden in China: a comprehensive analysis from 1990 to 2030 using GBD data (2024 · Scientific Reports · 被引 27)
• STING Agonist‐Loaded Nanoparticles Promotes Positive Regulation of Type I Interferon‐Dependent Radioimmunotherapy in Rectal Cancer (2023 · Advanced Science · 被引 26)